Marleen Dekker

2.8k total citations · 1 hit paper
28 papers, 2.3k citations indexed

About

Marleen Dekker is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Marleen Dekker has authored 28 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 12 papers in Cancer Research. Recurrent topics in Marleen Dekker's work include Genetic factors in colorectal cancer (15 papers), Cancer Genomics and Diagnostics (10 papers) and DNA Repair Mechanisms (8 papers). Marleen Dekker is often cited by papers focused on Genetic factors in colorectal cancer (15 papers), Cancer Genomics and Diagnostics (10 papers) and DNA Repair Mechanisms (8 papers). Marleen Dekker collaborates with scholars based in Netherlands, France and United Kingdom. Marleen Dekker's co-authors include Hein te Riele, Niels de Wind, Miroslav Radman, Anton Berns, Martin van der Valk, Jan‐Hermen Dannenberg, Dirk G. de Rooij, Sandra S. de Vries, P. de Boer and Esther B. Baart and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marleen Dekker

25 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

1995 679 citations Niels de Wind, Marleen Dekker et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marleen Dekker Netherlands	16	1.6k	936	644	619	321	28	2.3k
Paula Kristo Finland	22	1.0k 0.6×	2.0k 2.1×	1.6k 2.4×	794 1.3×	539 1.7×	33	3.0k
Sigurður Ingvarsson Iceland	29	2.0k 1.2×	574 0.6×	725 1.1×	905 1.5×	1.2k 3.6×	95	3.1k
Robin X Luo United States	9	2.2k 1.4×	183 0.2×	1.5k 2.3×	250 0.4×	256 0.8×	9	2.9k
Matty Verlaan–de Vries Netherlands	17	1.7k 1.0×	166 0.2×	755 1.2×	306 0.5×	202 0.6×	24	2.2k
Thomas Look United States	19	2.1k 1.3×	152 0.2×	882 1.4×	308 0.5×	299 0.9×	36	3.1k
Ashby J. Morrison United States	24	2.9k 1.8×	160 0.2×	487 0.8×	294 0.5×	232 0.7×	31	3.1k
J. Whang‐Peng United States	22	1.1k 0.7×	197 0.2×	867 1.3×	327 0.5×	375 1.2×	46	2.2k
Floyd H. Thompson United States	20	654 0.4×	146 0.2×	360 0.6×	349 0.6×	363 1.1×	28	1.1k
Vibeke Ahrenkiel Denmark	10	1.1k 0.7×	284 0.3×	451 0.7×	182 0.3×	116 0.4×	12	1.5k
Amélie Rodrigue Canada	19	1.6k 1.0×	72 0.1×	913 1.4×	261 0.4×	238 0.7×	30	2.0k

Countries citing papers authored by Marleen Dekker

Since Specialization

Citations

This map shows the geographic impact of Marleen Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen Dekker more than expected).

Fields of papers citing papers by Marleen Dekker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen Dekker. The network helps show where Marleen Dekker may publish in the future.

Co-authorship network of co-authors of Marleen Dekker

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen Dekker. A scholar is included among the top collaborators of Marleen Dekker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen Dekker. Marleen Dekker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bianchi, D. W., Guizela Huelsz‐Prince, Marleen Dekker, et al.. (2025). Zincore, an atypical coregulator, binds zinc finger transcription factors to control gene expression. Science. 389(6755). eadv2861–eadv2861.

Pieters, Wietske, Alexander Fish, A. Manuel Liaci, et al.. (2023). Unexpected moves: a conformational change in MutSα enables high-affinity DNA mismatch binding. Nucleic Acids Research. 51(3). 1173–1188. 9 indexed citations

Pieters, Wietske, et al.. (2020). Extensive trimming of short single-stranded DNA oligonucleotides during replication-coupled gene editing in mammalian cells. PLoS Genetics. 16(10). e1009041–e1009041. 2 indexed citations

Dekker, Marleen, et al.. (2019). Three-step site-directed mutagenesis screen identifies pathogenic MLH1 variants associated with Lynch syndrome. Journal of Medical Genetics. 57(5). 308–315. 7 indexed citations

Benedict, Bente, Marleen Dekker, Aslι Küçükosmanoğlu, et al.. (2018). Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells. eLife. 7. 39 indexed citations

Goverde, Anne, Marleen Dekker, Marco J. Bruno, et al.. (2017). Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity. PLoS Genetics. 13(5). e1006765–e1006765. 15 indexed citations

Vormer, Tinke L., Marleen Dekker, Shalin H. Naik, et al.. (2014). RB Family Tumor Suppressor Activity May Not Relate to Active Silencing of E2F Target Genes. Cancer Research. 74(18). 5266–5276. 13 indexed citations

Gerwen, Bastiaan van, et al.. (2014). Temozolomide Increases the Number of Mismatch Repair–Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome. Gastroenterology. 147(5). 1064–1072.e5. 23 indexed citations

Dekker, Marleen, Marieke Aarts, Robert G. Dekker, et al.. (2011). Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 715(1-2). 52–60. 11 indexed citations

10.

Aarts, Marieke, et al.. (2009). Gene Modification in Embryonic Stem Cells by Single-Stranded DNA Oligonucleotides. Methods in molecular biology. 530. 79–99. 10 indexed citations

11.

Dekker, Marleen, et al.. (2009). Generation of Double-Knockout Embryonic Stem Cells. Methods in molecular biology. 530. 205–218. 1 indexed citations

12.

Dekker, Marleen, et al.. (2006). Effective oligonucleotide-mediated gene disruption in ES cells lacking the mismatch repair protein MSH3. Gene Therapy. 13(8). 686–694. 31 indexed citations

13.

Aarts, Marieke, et al.. (2006). Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells. Nucleic Acids Research. 34(21). e147–e147. 44 indexed citations

14.

Dannenberg, Jan‐Hermen, Leontine Schuijff, Marleen Dekker, Martin van der Valk, & Hein te Riele. (2004). Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes & Development. 18(23). 2952–2962. 113 indexed citations

15.

Jansen, L.A.M., et al.. (2000). Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents. Toxicology Letters. 112-113. 245–250. 3 indexed citations

16.

Vries, Sandra S. de, Esther B. Baart, Marleen Dekker, et al.. (1999). Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes & Development. 13(5). 523–531. 282 indexed citations

17.

Wind, Niels de, Marleen Dekker, Nanna Claij, et al.. (1999). HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nature Genetics. 23(3). 359–362. 173 indexed citations

18.

Robanus-Maandag, Els C., Marleen Dekker, Martin van der Valk, et al.. (1998). p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes & Development. 12(11). 1599–1609. 245 indexed citations

19.

Wind, Niels de, Marleen Dekker, Anton Berns, Miroslav Radman, & Hein te Riele. (1995). Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82(2). 321–330. 679 indexed citations breakdown →

20.

Joling, P., Leendert J. Bakker, Jos A. G. van Strijp, et al.. (1993). Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. The Journal of Immunology. 150(3). 1065–1073. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact